Glaxosmithkline | GSK - Net Income

Stock Price
60.27
Daily Change
11.98 24.81%
Monthly
23.73%
Yearly
67.23%
Q1 Forecast
50.58

Glaxosmithkline reported GBP2.71B in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
Amgen USD 1.33B 1.88B Dec/2025
AstraZeneca USD 2.53B 83M Sep/2025
Aurora Cannabis CAD -51.47M 36.26M Sep/2025
Bausch Health Companies USD 179M 31M Sep/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Canopy Growth CAD -1.64M 39.89M Sep/2025
Corcept Therapeutics USD 19.67M 15.48M Sep/2025
Drreddys Laboratories INR 12.1B 2.08B Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
Glaxosmithkline GBP 2.71B 1.27B Sep/2025
J&J USD 5.12B 36M Dec/2025
Merck USD 2.96B 2.82B Dec/2025
Novartis USD 3.93B 96M Sep/2025
Pacira USD 5.43M 10.28M Sep/2025
Perrigo USD 7.5M 15.9M Sep/2025
Pfizer USD -1.65B 5.19B Dec/2025
Prestige Brands USD 46.7M 22.44M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
Supernus Pharmaceuticals USD -45.12M 67.62M Sep/2025
Takeda JPY 103.64B 115.44B Dec/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025
Zoetis USD 721M 3M Sep/2025